GLP Watchdog

Enhance MD vs Found

Neither Enhance MD nor Found has an FDA warning letter on record. On compounded semaglutide injection, Enhance MD costs $520 less a year at standing rates: $249 a month (billed every 4 weeks) against $289 a month (billed every 4 weeks) at Found. It is one of two products the two sell at comparable terms.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Enhance MD / Found

Enhance MD logo

Enhance MD

7.4/10

Found logo

Found

7.3/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection, billed every 4 weeks
$289/moCompounded semaglutide injection, billed every 4 weeks
States
40 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Enhance MDFull review
Visit FoundFull review

Both Enhance MD and Found are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Enhance MD 7.4, Found 7.3). How we are paid

What the record shows

  1. 01

    Neither Enhance MD nor Found has an FDA warning letter on record.

  2. 02

    Enhance MD names five pharmacies, all 503A. Found names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Enhance MD costs $520 less a year at standing rates: $249 a month (billed every 4 weeks) against $289 a month (billed every 4 weeks) at Found. It is one of two products the two sell at comparable terms.

  4. 04

    Only Found lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and Foundayo (orforglipron) pill.

  5. 05

    Found covers 10 states Enhance MD does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Enhance MD

Found

Compounded semaglutide injection

$249/moLower

$3,237 a year, 13 charges

$289/mo

$3,757 a year, 13 charges

Compounded tirzepatide injection

$329/moLower

$4,277 a year, 13 charges

$359/mo

$4,667 a year, 13 charges

Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Price includes
Medication, clinician visits, shipping, labs
Medication, clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None month to month; longer plans charge once per 12, 24 or 48 weeks
None (3-, 6- and 12-month prepaid plans optional)
Refunds
Full refund of the initial payment if found ineligible during onboarding; no returns on prescription products
Membership refundable within 3 days or before first consult; medication and renewals non-refundable

Read off each seller’s own pages. Enhance MD: October 17, 2026. Found: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Enhance MD

7.4/10
  • $520 a year less on compounded semaglutide injection
  • $390 a year less on compounded tirzepatide injection
  • Names its compounding pharmacy
Visit Enhance MD

The case for Found

7.3/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Enhance MD does not price
  • Lists 50 states against 40
  • Names no compounding pharmacy
Visit Found

Scores

Enhance MD 7.4 · Found 7.3 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

7.0A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
7.5

Accessibility10%

8.4A
vs
B
10.0

Support10%

8.5A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Enhance MD vs Found: questions

Neither Enhance MD nor Found has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Enhance MD names five pharmacies, all 503A. Found names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Enhance MD, by $520 a year at standing rates. Enhance MD: $249 a month (billed every 4 weeks), about $3,237 a year. Found: $289 a month (billed every 4 weeks), about $3,757 a year.
Enhance MD states you can cancel at any time; refunds: full refund of the initial payment if found ineligible during onboarding; no returns on prescription products. Found states you can cancel at any time; refunds: membership refundable within 3 days or before first consult; medication and renewals non-refundable.
Both Enhance MD and Found are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Enhance MD 7.4, Found 7.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks